NCT05802485Not yet recruiting
PANCREATIC CANCER: DYNAMIC ASSESSMENT AT ALL STAGES OF TREATMENT
PANCREATIC CANCER: DYNAMIC ASSESSMENT AT ALL STAGES OF TREATMENT: PANDORE-PANC-IPC 2021-082
Source: ClinicalTrials.gov · Last updated 6 Apr 2023 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The study consists of a 25 ml blood sample collection: * Before the start of treatment * Approximately 2 months after the start of induction chemotherapy * At the end of induction chemotherapy * Prior to local treatment (radiotherapy, surgery) * At the time of tumor progression Collection of tumor material: * During the initial diagnostic biopsy * On the operating room in case of surgery * At tumor biopsy in case of recurrence or progression (optional) As well as the completion of a questionnaire at inclusion.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 300 (estimated)
- First submitted
- 23 Nov 2022
- Start date
- 30 Apr 2023
- Primary completion date
- 1 Feb 2029
- Lead sponsor
- Institut Paoli-Calmettes
- Diseases
- Pancreatic cancer
- NCT number
- NCT05802485
What you commit to
- Study type: Interventional
- Planned participants: 300
- From 30 Apr 2023 to the primary completion date, 1 Feb 2029
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Metastatic disease
Age
- Person of legal age under legal protection (guardianship, curatorship or safeguard of justice) or unable to give consent.
Other
- Pancreatic tumor of a histological type other than adenocarcinoma
- Other tumor under treatment or for which treatments have been completed for \< 1 year
- Pregnant or breastfeeding women
- Person in an emergency situation
Who the study is looking for
- Non-metastatic pancreatic adenocarcinoma that is not immediately resectable (borderline and locally advanced tumors according to the NCCN 2020 classification)
- No previous treatment with surgery or chemotherapy
- Age \> 18 years
- General condition WHO 0-2 (patient whose general condition can allow medical treatment or surgery)
- Therapeutic management at the Paoli-Calmettes Institute
- Signature of the informed consent specific to the PANDORE-PANC study
- Patient affiliated to a social security system or benefiting from such a system
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.